A bill to provide that the trademark law does not require that each drug be manufactured in a tablet which is unique as to its size, color, and shape.

Amends the Trade-Mark Act of 1946 to permit same-use approved equivalent drugs to be manufactured in the form of a tablet which is the same size, color, and shape of the tablet of another drug without violating the prohibitions against false designations of origin or false descriptions or representations.